Although this pathway is not directly related to apoptosis resistance, it adds an important novel facet to the complex repertoire of mechanisms by which TRIM25 can promote tumor development and may, therefore, highlight the estimated benefits of TRIM25-targeting therapies for cancer treatment. This evidence concerns the gene TRIM25 and neoplasm.